Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3198318 | Journal of Allergy and Clinical Immunology | 2012 | 16 Pages |
Abstract
This study does not support the existence in human asthma of the full M2 phenotype described to date but points to upregulation of CCL17 in both patients with mild and those with moderate asthma, providing a further source for this ligand of CCR4+ cells that contributes to airways inflammation. CCL17 expression is corticosteroid resistant but suppressed by PI3K enzyme inhibitors.
Keywords
PI3KPerCP-Cy5.5PE-Cy7APC-Cy7MDMARG1BALAPCFACSNF-κBMMParginase 1AsthmaallophycocyaninSteroidAlexa Fluor 647COPDChronic obstructive pulmonary diseaseLineagefluorescence-activated cell sortingnuclear factor κBphycoerythrinPhosphatidylinositol 3-kinasebronchoalveolar lavagelactate dehydrogenaseLDHLinmatrix metalloproteinaseMacrophageMonocyte-derived macrophageChemokine
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Karl J. PhD, Timothy S.C. MB BS, Jon A. BSc (Hons), Victoria BM, Caroline BA (Hons), Ratko MD,